This month articles focus on which protective devices could lower radiation doses received by the brain, a step-by-step manual for planning and performing bifurcation PCI; 30-day outcomes in the SAVI-TF registry using the ACURATE neo prosthesis; a meta-analysis of how bioprosthetic aortic valve leaflet thrombosis detected by MDCT is associated with adverse cerebrovascular events and a study looking at patients admitted with cardiovascular events attributed to bare metal and first- and second-generation DES failure.
This year begins with a consensus document from the European Bifurcation Club on PCI for the left main stem and other bifurcation lesions. We publish an executive summary from the ESC-EAPCI Task Force looking at BRS in PCI. Also, a new TAVI risk scoring system – the STS/ACC TAVR score and using iFR evaluations of coronary lesions in patients with severe AS undergoing TAVI.
This issue highlights the best of Asian clinical science from the history of PTCA to the latest cutting edge devices and procedures of interest in the region and internationally.
You are at AsiaPCR next week, don't miss to pick up your free copy!
In carotid stenting, articles this month include one on a new-generation of mesh-covered stents. From the SCAAR registry, PCI outcomes with the Absorb BVS, another on differences between the Absorb BVS and the Mirage BRMS. In valvular treatments, an in vitro experiment using a novel synchronised diastolic injection method to reduce contrast volume during aortography for AR and a look at the low pacemaker rates following ACURATE neo THV implantation.
This month read about a new fluoroscopic technology that reduces radiation dosage facilitating PCI of CTOs; or the poorly understood characteristics and implications of recurrent SCAD in women. Learn about a new TMV replacement system, NaviGate, explore the midterm performance of a restorative pulmonary valved conduit or consider the best antiaggregant or anticoagulant therapy after TAVI.
Offering a comprehensive and interactive guidance through intravascular OCT, the second edition of this educational tool
includes additional content and new features that will ensure a customizable experience.
TAVI or redo surgery for failing surgical aortic bioprostheses? Which should you choose? Read about this subject and others including TAVI in mixed versus pure stenotic aortic valve disease, the CHANGE DAPT observational study exploring clopidogrel or ticagrelor in ACS syndrome patients, IV enoxaparin anticoagulation in percutaneous left atrial cardiac procedures and the assessment of long-term mortality in patients with complex CAD undergoing PCI.
From MR CLEAN, a look at MT in patients with acute ischaemic stroke and atrial fibrillation; an article on the influence of myocardium mass subtended to coronary stenosis on IMR and implications for the invasive assessment of microcirculatory function in ischaemic heart disease; the predictive value of the ATI score in relation to final infarct size in STEMI patients; the impact of a crossing strategy on midterm outcomes following percutaneous revascularisation of coronary CTOs and, from the German (AQUA) registry, insights into volume-outcome relationships with transfemoral TAVI.
This issue introduces a new TMVR device, examines subclinical leaflet thickening and stent frame geometry in self-expanding THVs, fracturing mechanics before VIV therapy of small aortic heart valves, how high-pressure balloon fracturing of a Mitroflow bioprostheses could facilitate aortic VIV implantation and an in vitro look at stent malapposition and stent thrombosis.
In this EEP, with important implications for both trialists and patients, the investigators report on severe or major periprocedural bleeding based on the widely accepted GUSTO, TIMI, ACUITY and BARC classifications in the analysis of about 25,000 patients from the CHAMPION PCI, CHAMPION PLATFORM and CHAMPION PHOENIX trials.
Fifteen years after the first percutaneous valve replacement and on the 40th anniversary of angioplasty, this supplement goes beyond history with articles on the state-of-the-art in aortic, mitral and tricuspid valve treatments. New devices, emerging data and the challenge of durability as treatment expands from high to lower risk patients.
Herein, we present 3 important studies concerning the use of transcatheter aortic valve implantation (TAVI) within small degenerated surgical bioprosthetic valves. In such cases, left main coronary occlusion and high post-implant gradients are not infrequently encountered, increasing mortality and curtailing symptomatic improvement.
Browse the 3 last EEP's publidhed on September 10th.
This special edition is commemorating forty years of angioplasty. Published at the same time as ESC Congress 2017 in Barcelona, it highlights the singular achievement of Andreas Grüntzig, but also captures the advances and collaboration by specialists fr
The result of two years’ collaborative work with many of the EAPCI national societies and working groups, special guest editors E. Barbato and D. Dudek present the first edition of this essential snapshot into the way we practice interventional cardiology today. Dedicated to systematic data collection comparing such parameters as the adoption rate of guidelines in each country, the role of budget and reimbursement, the penetration of innovation, response to indications or the use of the different techniques, learn how these results will help focus the various programmes encouraging greater treatment access and equality, such as the recently launched Valve for Life initiative. Watch now.
This issue includes 6-month FIM results of a surface-modified coronary stent system in CS, the use of 2nd-generation ultra-hydrophilic stent platforms to promote early vascular healing and minimise late tissue response, as well as a look at the feasibility and safety of vitamin K antagonist monotherapy in AF patients undergoing TAVI or aspirin use alone after LAAO in AF.
The EAPCI is committed to monitoring the heterogeneity of our practice, spotlight obstacles to guideline implementation and note the dynamics of harmonisation across Europe today. This special supplement does just that, providing a detailed look at trends in coronary and structural interventions in 16 countries, offering a future “foundation for a prospective, regular and systematic data collection”.
From a critical study measuring the radiation dose absorbed by operators to the use of MRA to see whether renal denervation might cause luminal narrowing, this issue also includes an analysis of the the Swiss TAVI registry looking at the latest generation of the Evolut R bioprosthesis, CT angiography planning to improve localisation of infarct and procedural success and a comparison of rates of post-procedural MI following SAVR or TAVI.
This edition contains insights into possible mechanical causes of scaffold thrombosis, long-term results of PPVI, an assessment and description of CAD in patients with HIV undergoing PCI, results from the TRAMI registry in patients undergoing MitraClip edge-to-edge mitral valve repair and the TICOMA study on the effects of ticagrelor administered to comatose patients.
This issue highlights the tricupid valve (TV) with articles on the impact of tricuspid regurgitation (TR) from the TRAMI registry, the feasibility of TV clipping, computed tomography in patients with TR prior to transcatheter valve repair and first implantation of the percutaneous Micra leadless pacemaker after TV repair for lead-associated severe TR.
The first edition of 2017 looks at the future with an article on the feasibility of telestenting using a combination of robotics and telecommunications. Other articles include an examination of the selective use of DES in STEMI and results of the ORIENT and PLATINUM PLUS trials.
We end 2016 with articles on rotational atherectomy, implantation of TAVI prostheses into degenerated mitral valves and failed annuloplasty rings, released plaque during BRS implantation and an OCT comparison of vascular response between self-expanding, bare metal stents and a drug-eluting stents in femoral lesions.
This month EuroIntervention brings you an EAPCI survey on bivalirudin use in patients with ACS, continued focus on BRS with 2-year outcomes of the ABSORB II trial and insights from the ABSORB Japan trial. NSTEMI is the subject of the SWEDEHEART and Finish trends in coronary revascularisations between 1994 and 2013 are of interest among others…
To better serve our authors and readers, Just Accepted Articles (JAA) will be published online before copy editing and typesetting, in PDF format.
Don’t wait the journal’s publication to discover new content!
This month we have a wide range of articles including an in-depth look at the importance of quantitative multislice computed tomography in the assessment of the mitral valvular complex for transcatheter mitral valve interventions, a meta-analysis of the impact of atrial fibrillation on clinical outcomes in TAVI and aspects of the CoreValve experience at four-years.
Guest editors C. Tamburino, S. Windecker, N. Piazza, M. Haude and B. Prendergast have created a special EuroIntervention supplement mirroring the spirit and content of PCR London Valves - the world’s largest course specifically addressing the rapidly expanding and innovative field of transcatheter therapies for valvular heart disease. The 4 sections deal with the field’s most interesting and novel elements: aortic, mitral and tricuspid interventions as well as imaging in heart valve interventions. A complement to the meeting, and a reference document for the future.
This month, articles are linked to PCR London Valves, such as results from the EAPCI survey on the current status of THV therapy in Europe, evaluating the depth in valve-in-valve interventions, redo TAVI and a new THV concept. We also publish a consensus on going forward responsibly with bioresorbable scaffolds.
Find articles focussed on a novel monorail infusion catheter for volumetric coronary blood flow measurement and three TAVI papers: on the repositionable Lotus valve; the resheathable Portico system and five-year haemodynamic outcomes of 1st-generation SAPIEN THVs.
Number 100 includes articles on VARC endpoint definition compliance rates in TAVI, predictors of high-sensitivity cardiac troponin in stable patients undergoing CA, mechanical strategies to enhance myocardial salvage during primary-PCI in STEMI patients and the relationship between diabetes, platelet reactivity and the SYNTAX score to 1-year clinical outcomes in patients with non-STEMI ACS undergoing PCI.
Find articles focused on stroke rates after carotid stenting, the impact of CTO location on long-term mortality in STEMI patients and, in TAVI, a look at filter-based cerebral embolic protection and the effect of resting heart rates on clinical outcomes in high-risk patients.
This month's issue includes papers on the impact of BRS for small lesions and CTO's. Furthermore results of Sapien 3 in intermediate risk patients and the results of European Registry of Carotid Artery Stenting.
This month's issue includes papers on the BRS for in-stent restenosis,simulation training for the trainee cardiologist and a consensus paper on the use of the AMPLATZER Amulet device for left atrial appendage occlusion.
This month's issue includes papers on the prognostic importance of renal function in patients undergoing structural cardiac interventions, the natural history of atherosclerosis and two proof of concept papers within the field of mitral annuloplasty
Novel retrograde approach for percutaneous treatment of chronic total occlusions of the right coronary artery using ipsilateral collateral connections: a European centre experience by K. Mashayekhi et al.
This month includes an excellent new assessment modelling complex issues of FFR in the main stem which formulates new mathematical guidelines to facilitate the work of the clinician, an example of retrograde recanalisation of CTOs using ipsilateral collateral connections and articles on ViV implantations
This month's issue includes a study and an editorial commentary on the impact of the J-CTO score on clinical outcomes in terms of TLR, a report and an editorial commentary on the 20-fold increase in annual TAVI implants in Germany
This month’s issue includes IVUS guidance for complete percutaneous revascularisation, a proposal for a SYNTAX revascularisation index, an expert review of stenting of coarctation of the aorta and a novel technique of Parachute implantation in conjunction with MitraClipping.
Paul Cummins, managing editor of EuroIntervention, and Stephan Windecker, President of the EAPCI, talk about the link between the EAPCI and its scientific voice, EuroIntervention Journal, celebrating its 10-year anniversary this year
The final issue of 2014 has a strong focus on the challenges within the transcatheter valve-in-valve arena not only for failing prosthetic valves but also for mitral valve-in-ring. View the table of contents
This issue includes papers on direct catheter-based thrombectomy in acute ischaemic stroke, data from GARY and FRANCE 2 on low-flow, low-gradient severe aortic stenosis and 3D TEE for selecting/ guiding MitraClip interventions. View the table of contents
Prof. Maisano discusses his contribution to Dr. Tarsia's paper on "How should I treat aortic valvular stenosis in a high-risk surgical patient who previously received a stent in the ostial left main?" (Article)
Sebastian Ewen asks questions to Bernard Waeber, co-author of Assessment of drug compliance in patients with high blood pressure resistant to antihypertensive therapy, article published in EuroIntervention Journal Supplement on Resistant Hypertension Treatments, May 2013
Sebastian Ewen asks questions to Peter J. Blankestijn, co-author of Pathophysiology I: the kidney and the sympathetic nervous system, article published in EuroIntervention Journal Supplement on Resistant Hypertension Treatments, May 2013.